HCL’s Smart Clinical Trial solution aims to make clinical trials smarter, faster, and more optimized by accelerating the discovery-to-market journey for a drug.

Pharmaceutical companies are continually looking to adopt faster and effective drug development models to address issues of competition, consolidation, effective safety monitoring along with management of patient recruitment and retention issues during trials. The solution allows all stakeholders involved in clinical trials for a drug to leverage Internet of Things (IoT) technology and perform 'day-to-day' safety monitoring of the patients participating in the trial/ program, hence boosting protocol adherence and REMS compliance.

This helps in early identification of trends/ patterns contributing to enhancement in decision-making capabilities for the outcome of the trial, in-turn saving time, effort, and capital for pharmaceutical companies. By enabling e-visits through various smart devices to capture vital signs and e-diary data of trial subjects apart from scheduled visits, the solution helps investigators/ clinicians to view patient data in real-time by leveraging the smart ‘Patient Portal’ and providing safety monitoring and care through multi-disciplinary teams effectively and immediately. Thus the solution helps improve patient safety, faster completion of clinical trials, and compliance with regulatory demands.